Abstract
Using oligonucleotide microarray data of 45 hepatocellular carcinoma (HCC) samples, we evaluated gene expression in hepatitis B virus-positive and hepatitis C virus-positive HCCs (HBV- and HCV-HCCs) for an association with liver cirrhosis (LC). In all, 89 genes were expressed differentially between HBV-HCCs associated with LC and those not associated with LC. Among them, tumors from LC patients showed significantly lower expression levels of 72 genes and significantly higher levels of 17 genes than the levels found in tumors from non-LC patients. The former included genes responsible for signal transduction, transcription, metabolism, and cell growth. The latter included a tumor suppressor gene and a cell-growth-related gene. Only eight genes were expressed differentially between HCV-HCCs associated with and without LC. Our findings provide as a framework for clarifying the role of LC in HBV- and HCV-related hepatocarcinogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- HCC:
-
hepatocellular carcinoma
- HBV:
-
hepatitis B virus
- HCV:
-
hepatitis C virus
- LC:
-
liver cirrhosis
- HBX protein:
-
hepatitis B X protein
- Gene abbreviations are used from Locus Link:
References
Bode BP, and, Souba WW . (1999). J. Parenter. Enteral. Nutr., 23, S33–S37.
Delpeuch O, Trabut JB, Carnot F, Feuillard J, Brechot C and Kremsdorf D . (2002). Oncogene, 21, 2926–2937.
Goldenberg D, Ayesh S, Schneider T, Pappo O, Jurim O,, Eid A, Fellig Y, Dadon T, Ariel I, de Groot N, Hochberg A and Galun E . (2002). Mol. Carcinogen., 33, 113–124.
Grimberg A . (2000). Mol. Genet. Metab., 70, 85–98.
Huang CJ, Chen YH and Ting LP . (2000). J. Biomed. Sci., 7, 160–168.
Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C and Harris CC . (2001). Oncogene, 20, 3620–3628.
Iizuka N, Hazama S, Yoshimura K, Yoshino S, Tangoku A, Miyamoto K, Okita K and Oka M . (2002a). Int. J. Cancer, 99, 286–291.
Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K and Suzuki T . (1995). Cancer Res., 55, 652–657.
Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S and Hamamoto Y . (2002b). Cancer Res., 62, 3939–3944.
Kao JH, Chen PJ, Lai MY and Chen DS . (2000). Gastroenterology, 118, 554–559.
Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH and Koshy R . (1990). Nature, 343, 457–461.
Kim JS, Crooks H, Dracheva T, Nishanian TG, Singh B, Jen J and Waldman T . (2002). Cancer Res., 62, 2744–2748.
Koike K, Tsutsumi T, Fujie H, Shintani Y and Kyoji M . (2002). Oncology, 62, 29–37.
Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY and Lee SD . (2002). Oncogene, 21, 4801–4811.
Lau WY, Lai PB, Leung MF, Leung BC, Wong N, Chen G, Leung TW and Liew CT . (2000). Oncol. Res., 12, 59–69.
Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM and Isaacs WB . (2001). Cancer Res., 61, 4683–4688.
Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y and Nakamura Y . (2001). Cancer Res., 61, 2129–2137.
Okita K, Sakaida I and Hino K . (2002). Oncology, 62, 24–28.
Okuda K . (2000). J. Hepatol., 32, 225–237.
Poynard T, Bedossa P and Opolon P . (1997). Lancet, 349, 825–832.
Schafer DF and Sorrell MF . (1999). Lancet, 353, 1253–1257.
Shirota Y, Kaneko S, Honda M, Kawai HF and Kobayashi K . (2001). Hepatology, 33, 832–840.
Smith TA . (1999). Br. J. Biomed. Sci., 56, 285–292.
Sobin LH and Wittekind C . (2002). TNM Classification of Malignant Tumours, 6th edn., UICC, Wiley-Liss, New York, pp. 81–83.
van der Flier A, Kuikman I, Kramer D, Geerts D, Kreft M, Takafuta T, Shapiro SS and Sonnenberg A . (2002). J. Cell Biol., 156, 361–376.
Xu L, Hui L, Wang S, Gong J, Jin Y, Wang Y, Ji Y, Wu X, Han Z and Hu G . (2001). Cancer Res., 61, 3176–3681.
Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, Yan Q, Cai T, Zhang X, Xiao HS, Qu J, Liu F, Huang QH, Cheng ZH, Li NG, Du JJ, Hu W, Shen KT, Lu G, Fu G, Zhong M, Xu SH, Gu WY, Huang W, Zhao XT, Hu GX, Gu JR, Chen Z and Han ZG . (2001). Proc. Natl. Acad. Sci. USA, 98, 15089–15094.
Acknowledgements
This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (No. 12671230).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iizuka, N., Oka, M., Yamada-Okabe, H. et al. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene 22, 3007–3014 (2003). https://doi.org/10.1038/sj.onc.1206401
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206401
Keywords
This article is cited by
-
Harnessing big ‘omics’ data and AI for drug discovery in hepatocellular carcinoma
Nature Reviews Gastroenterology & Hepatology (2020)
-
LncRNA MYCNOS facilitates proliferation and invasion in hepatocellular carcinoma by regulating miR-340
Human Cell (2020)
-
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma
Nature Biotechnology (2009)
-
MicroRNAs: Control and Loss of Control in Human Physiology and Disease
World Journal of Surgery (2009)
-
Comparative Analysis of Proteome and Transcriptome in Human Hepatocellular Carcinoma using 2D-DIGE and SAGE
The Protein Journal (2008)